In summary, our investigation of the MPE LADC immune landscape demonstrates the clinically relevant immunogenic potential of PD-L1, and the significance of cytoplasmic pattern recognition receptor and type I interferon signalling pathways in the tumour suppressive process. This evidence concerns the gene CD274 and neoplasm.